AIM ImmunoTech Inc
AIM3.030USD
+0.200+7.07%
交易中 （美東）報價延遲15分鐘
219.04M總市值
虧損本益比TTM
關於 AIM ImmunoTech Inc 公司
AIM ImmunoTech Inc. 是一家免疫製藥公司。該公司專注於研究和開發用於治療多種癌症、免疫疾病和病毒性疾病的療法。其旗艦產品是 Ampligen (rintatolimod)，一種大分子核糖核酸 (RNA) 分子藥物，以及 Alferon N 注射劑 (干擾素 α)。其主要產品是一種名爲 Ampligen (rintatolimod) 的試驗藥物，這是一種 dsRNA 和高度選擇性 TLR3 激動劑免疫調節劑，在臨牀試驗中具有廣譜活性，可用於治療全球重要的癌症、病毒性疾病和免疫系統疾病。Ampligen 已獲准在阿根廷共和國進行商業銷售，用於治療嚴重的慢性疲勞綜合症 (CFS)。Alferon N 注射劑是一種天然 α 干擾素的注射劑，已獲准在美國和阿根廷銷售，用於 18 歲或以上患者的難治性或複發性外生殖器疣的病竈內治療。
公司簡介
公司代碼AIM
公司名稱AIM ImmunoTech Inc
上市日期Jul 12, 1996
CEOMr. Thomas K. Equels, Esq., J.D.
員工數量21
證券類型Ordinary Share
年結日Jul 12
公司地址2117 Sw Highway 484
城市OCALA
上市交易所NYSE American Consolidated
國家United States of America
郵編32801
電話13524487797
網址https://aimimmuno.com/
公司代碼AIM
上市日期Jul 12, 1996
CEOMr. Thomas K. Equels, Esq., J.D.
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Thomas K. Equels, Esq., J.D.
Mr. Thomas K. Equels, Esq., J.D.
President, Chief Executive Officer, Executive Vice Chairman of the Board
President, Chief Executive Officer, Executive Vice Chairman of the Board
38.88K
+0.54%
Mr. Ted D. Kellner
Mr. Ted D. Kellner
Independent Director
Independent Director
19.70K
+196850.00%
Dr. William M. Mitchell, M.D., Ph.D.
Dr. William M. Mitchell, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
5.22K
+60.53%
Ms. Nancy K. Bryan
Ms. Nancy K. Bryan
Independent Director
Independent Director
2.92K
+31.96%
Mr. David I. Chemerow
Mr. David I. Chemerow
Independent Director
Independent Director
642.00
+232.64%
Mr. Robert (Rob) Dickey, IV
Mr. Robert (Rob) Dickey, IV
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Jenene Thomas
Ms. Jenene Thomas
Investor Relations
Investor Relations
--
--
Mr. Peter W. Rodino, III
Mr. Peter W. Rodino, III
Chief Operating Officer, Executive Director - Governmental Relations, General Counsel, Company Secretary
Chief Operating Officer, Executive Director - Governmental Relations, General Counsel, Company Secretary
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Thomas K. Equels, Esq., J.D.
Mr. Thomas K. Equels, Esq., J.D.
President, Chief Executive Officer, Executive Vice Chairman of the Board
President, Chief Executive Officer, Executive Vice Chairman of the Board
38.88K
+0.54%
Mr. Ted D. Kellner
Mr. Ted D. Kellner
Independent Director
Independent Director
19.70K
+196850.00%
Dr. William M. Mitchell, M.D., Ph.D.
Dr. William M. Mitchell, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
5.22K
+60.53%
Ms. Nancy K. Bryan
Ms. Nancy K. Bryan
Independent Director
Independent Director
2.92K
+31.96%
Mr. David I. Chemerow
Mr. David I. Chemerow
Independent Director
Independent Director
642.00
+232.64%
Mr. Robert (Rob) Dickey, IV
Mr. Robert (Rob) Dickey, IV
Chief Financial Officer
Chief Financial Officer
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 7月12日 週六
更新時間: 7月12日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Equels (Thomas K)
1.41%
The Vanguard Group, Inc.
0.88%
Kellner (Theodore D)
0.71%
Deutsch (Todd A)
0.62%
BlackRock Institutional Trust Company, N.A.
0.25%
Other
96.12%
持股股東
持股股東
佔比
Equels (Thomas K)
1.41%
The Vanguard Group, Inc.
0.88%
Kellner (Theodore D)
0.71%
Deutsch (Todd A)
0.62%
BlackRock Institutional Trust Company, N.A.
0.25%
Other
96.12%
股東類型
持股股東
佔比
Individual Investor
12.10%
Investment Advisor
4.36%
Investment Advisor/Hedge Fund
1.03%
Hedge Fund
0.74%
Venture Capital
0.11%
Other
81.65%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
68
140.24K
18.35%
-21.39K
2025Q1
83
99.85K
13.13%
-1.64M
2024Q4
79
10.59M
16.61%
-4.59M
2024Q3
75
14.47M
24.79%
+767.12K
2024Q2
74
13.00M
23.76%
+4.07M
2024Q1
77
8.58M
17.30%
-354.68K
2023Q4
77
8.35M
17.07%
-576.60K
2023Q3
80
8.49M
17.46%
-718.46K
2023Q2
77
5.43M
11.23%
-869.40K
2023Q1
81
5.73M
11.83%
-1.19M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Equels (Thomas K)
38.88K
5.09%
+210.00
+0.54%
Jun 13, 2025
The Vanguard Group, Inc.
24.44K
3.2%
+4.56K
+22.91%
Mar 31, 2025
Kellner (Theodore D)
19.70K
2.58%
+19.68K
+196850.00%
Apr 11, 2025
Deutsch (Todd A)
17.16K
2.25%
--
--
Dec 19, 2024
BlackRock Institutional Trust Company, N.A.
6.98K
0.91%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
5.31K
0.7%
+673.00
+14.50%
Mar 31, 2025
Mitchell (William M)
5.22K
0.68%
+1.97K
+60.53%
Apr 11, 2025
Rodino (Peter W III)
4.02K
0.53%
+5.00
+0.12%
Apr 04, 2025
Appelrouth (Stewart L.)
3.89K
0.51%
+670.00
+20.82%
Dec 31, 2024
Renaissance Technologies LLC
3.18K
0.42%
+575.00
+22.07%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Mar 03, 2025
Merger
100<1
公告日期
類型
比率
Mar 03, 2025
Merger
100<1
